Selling And Administration Expenses تغيير تاريخ
AbbVie USD 3.25B 40M 2025-06
Aena EUR 170.14M 8.19M 2025-03
Alcon AG USD 813M 11M 2025-03
Almirall EUR 91.3M 55.52M 2025-03
Amarin USD 36.57M 397K 2025-03
Amgen USD 1.69B 4M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Bayer EUR 3.55B 162M 2025-06
Biogen USD 583.8M 11.3M 2025-06
BMW EUR 2.7B 311M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Essilor EUR 1.09B 2.08B 2025-06
Fresenius EUR 740M 97M 2025-06
Fresenius Medical Care EUR 792M 41M 2025-06
Galapagos EUR 30.67M 13.12M 2025-06
Genmab DKK 144M 18M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
GRIFOLS EUR 282.76M 41.9M 2025-06
Hikma Pharmaceutical USD 288M 8M 2024-12
J&J USD 5.89B 777M 2025-06
Mercedes-Benz AG EUR 3.12B 62M 2025-06
Merck EUR 1.48B 9M 2025-06
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Novo Nordisk 18.85B 2.74B 2025-06
Orion EUR 96.7M 12.4M 2025-06
Pfizer USD 3.42B 406M 2025-06
Philips EUR 1.24B 9M 2025-06
Recordati EUR 186.98M 5.59M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
Sanofi EUR 1.24B 1.44B 2024-12
SAP EUR 2.22B 370M 2025-06
UCB EUR 1.29B 221M 2024-12
Vinci EUR 197M 49M 2025-06
Volkswagen EUR 8.73B 44M 2025-06


Sanofi مصاريف البيع والإدارة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.